The independent platform for news, articles and advice for professionals in laboratory medicine

NHS expands home testing for bowel cancer

The NHS is expanding home testing for bowel cancer as it aims to detect the disease earlier. Hundreds of thousands more people will be sent a home-testing kit as the lifesaving screening programme is now being made available to individuals aged 54 in England.

People aged 54 will now automatically receive a home test kit every two years by post when they become eligible. The kit, known as the faecal immunochemical test (FIT), checks for blood in a small stool sample, which can be a sign of bowel cancer. The phased expansion to people aged 54 years means an additional 830,000 people in England will now be eligible for the screening test, with London, which has the lowest uptake in the country, amongst the first places to roll out to this age group.

This significant expansion of the national bowel screening programme is the latest step in the NHS’s drive to find cancers at an earlier stage when they are easier to treat. Those newly eligible will receive an invitation letter and will be sent their test with full instructions and prepaid return packaging. Results are sent back to participants, along with information about further tests, if needed. Through regular screening, the programme aims to diagnose bowel cancers at an earlier stage, increasing the chances of successful treatment and survival.

Steve Russell, National Director for Vaccinations and Screening at NHS England, said: “Lives are saved when cancers are caught early and this expansion of our bowel cancer screening programme to those aged 54 will help to spot signs of bowel cancer sooner, and potentially save thousands of lives. We are seeing positive uptake of the home testing FIT kits, with over two thirds of those eligible returning their tests, but we want to see even more people taking up the offer.”

Early detection of bowel cancer, the third most common type of cancer in England, can significantly improve treatment outcomes. Since the FIT kit was introduced into the screening programme in April 2019, national uptake has increased from 59.2% to 67.8%. The FIT kit is more convenient to use than the previous home test as it only requires one sample which can be done at home and is then returned in a sealed bottle.

 

Upcoming Events

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
16 May, 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24 May, 2024

Med-Tech Innovation Expo

NEC, Birmingham
5-6 June, 2024

UK NEQAS Blood Coagulation: Clinical and Laboratory Haemostasis 2024

Sheffield Hallam University
5-6 June, 2024

LabMedUK24

DoubleTree by Hilton Brighton Metropole
10-12 June, 2024

Infection Diagnostics Symposium 2024

IET Austin Court, Birmingham
26-27 June, 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
16 May, 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24 May, 2024

Med-Tech Innovation Expo

NEC, Birmingham
5-6 June, 2024

UK NEQAS Blood Coagulation: Clinical and Laboratory Haemostasis 2024

Sheffield Hallam University
5-6 June, 2024

LabMedUK24

DoubleTree by Hilton Brighton Metropole
10-12 June, 2024

Infection Diagnostics Symposium 2024

IET Austin Court, Birmingham
26-27 June, 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025